Cargando…
Erratum: Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434632/ https://www.ncbi.nlm.nih.gov/pubmed/36060008 http://dx.doi.org/10.3389/fphar.2022.976792 |
| _version_ | 1784780919145496576 |
|---|---|
| author | Frontiers Production Office, |
| author_facet | Frontiers Production Office, |
| author_sort | Frontiers Production Office, |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9434632 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94346322022-09-02 Erratum: Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence Frontiers Production Office, Front Pharmacol Pharmacology Frontiers Media S.A. 2022-08-18 /pmc/articles/PMC9434632/ /pubmed/36060008 http://dx.doi.org/10.3389/fphar.2022.976792 Text en Copyright © 2022 Frontiers Production Office. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Frontiers Production Office, Erratum: Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence |
| title | Erratum: Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence |
| title_full | Erratum: Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence |
| title_fullStr | Erratum: Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence |
| title_full_unstemmed | Erratum: Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence |
| title_short | Erratum: Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence |
| title_sort | erratum: cefiderocol for the treatment of multidrug-resistant gram-negative bacteria: a systematic review of currently available evidence |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434632/ https://www.ncbi.nlm.nih.gov/pubmed/36060008 http://dx.doi.org/10.3389/fphar.2022.976792 |
| work_keys_str_mv | AT frontiersproductionoffice erratumcefiderocolforthetreatmentofmultidrugresistantgramnegativebacteriaasystematicreviewofcurrentlyavailableevidence |